- A nasal spray therapy using extracellular vesicles (EVs) carrying microRNAs can reverse brain aging by reducing neuroinflammation and restoring memory.
- The therapy, developed by Texas A&M researchers, shows effects within weeks and lasts months, with potential applications for dementia, stroke, and cognitive aging.
- Intranasal delivery allows direct brain treatment without invasive procedures, targeting immune cells to suppress inflammatory pathways and recharge neuronal mitochondria.
- The treatment improved cognitive functions in models, such as object recognition and environmental adaptation, with consistent results across both genders.
- A U.S. patent has been filed, backed by the National Institute on Aging, highlighting a shift towards 'successful brain aging' for healthier, longer lives.